AFJK

Aimei Health Technology Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth 0/10
  • Momentum 9/10
Aimei Health Technology sales and earnings growth
AFJK Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y -32.26%
  • FCF Y/Y -50.26%
Aimei Health Technology gross and profit margin trends
AFJK Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 2.80%
Aimei Health Technology net debt vs free cash flow
AFJK Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 2.3
  • Interest coverage NA

Aimei Health Technology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Shell Companies stocks ↗